News

Filter

Current filters:

None

Popular Filters

7885 to 7909 of 8753 results

Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida

16-11-2011

Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

New legislative amendments may result in huge losses for global pharma producers in Russia

16-11-2011

Sergei Lisovsky, a well-known Russian senator and public figure, has put forward an initiative to make…

EuropeGenericsLegalPharmaceuticalPricing

Bayer plans further capital spending of 1.8 billion euros in Asia

16-11-2011

German pharma, crop and material sciences group Bayer (BAY: DE) this morning disclosed plans to further…

Asia-PacificBayerFinancialMarkets & MarketingPharmaceutical

Mixed results for AstraZeneca in study comparing Crestor with Lipitor

16-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) presented mixed results from a study comparing its cholesterol…

AstraZenecaCardio-vascularCrestorLipitorPfizerPharmaceuticalResearch

Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business

15-11-2011

Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million

15-11-2011

UK specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) says it has disposed of the epilepsy drug Mysoline…

Laboratoires SERBMergers & AcquisitionsMysolineNeurologicalPharmaceuticalSinclair IS Pharma

Increase in US drug recalls and warning caused by manufacturing errors and regulatory non-compliance issues, says GBI

15-11-2011

The numbers of warning letters and drug recalls issued by and reported to the US Food and Drug Administration…

BiotechnologyNorth AmericaPharmaceuticalRegulation

Executive appointments at Merck KGaA and Pharmalink

15-11-2011

Germany’s Merck KGaA (MRK: DE) has announced that Joachim Christ will join the company on January…

ManagementMerck KGaAPharmaceuticalPharmaLink

Genzyme’s MS drug Lemtrada shows significant efficacy versus Rebif

15-11-2011

US biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) says that the Phase…

BayerGenzymeLemtradaNeurologicalPharmaceuticalRebifResearchSanofi

Japanese drug re-pricing issues raised by former Health Minister over TPP

15-11-2011

Japan’s former Health Minister, Yoichi Masuzoe, and current leader of the New Renaissance Party,…

Asia-PacificMarkets & MarketingPharmaceuticalPricing

Angiotech opts out of cardiovascular cell therapy program with Athersys

15-11-2011

Regenerative medicines firm Athersys (Nasdaq: ATHX) says that Canada’s Angiotech Pharmaceuticals…

AngiotechAthersysBiotechnologyFinancialLicensingMergers & Acquisitions

Dyax and Sigma Tau unit pull EU filing on Kalbitor

15-11-2011

USA-based Dyax Corp (Nasdaq: DYAX) says it reached agreement with Defiante Farmaceutica, a unit of privately-held…

Defiante FarmaceuticaDyax CorpEuropeKalbitorPharmaceuticalRare diseasesRegulationSigma Tau

APEC Summit endorses Principles for Industry Codes of Ethics for pharma

14-11-2011

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) said yesterday…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Kenya gets $345 million from Global Fund for HIV/AIDS fight

14-11-2011

Over the next few weeks, Kenya will be signing a $345 million grant agreement with the Global Fund to…

Anti-viralsFinancialHealthcarePharmaceuticalRest of the World

Faes Farma licences bilastine´s marketing rights in Indonesia to Kalbe

14-11-2011

Spanish drugmaker Faes Farma has signed a licence agreement for the commercialization of its antihistamine…

Asia-PacificbilastineFaes FarmaKalbe PharmaLicensingPharmaceuticalRespiratory and Pulmonary

Another FDA rejection for Alimera’s DME drug Iluvien

14-11-2011

Shares of US ophthalmic drug develop Alimera Sciences (Nasdaq: ALIM) plunged nearly 73% to $2 on Friday,…

Alimera SciencesIluvienNorth AmericaOphthalmicsPharmaceuticalpSividaRegulation

Novartis’ alisporivir may become first interferon-free oral for hepatitis C G2/G3

14-11-2011

The clear conclusion from a clinical trial of alisporivir (DEB025, from Swiss drug major Novartis [NOVN:…

alisporivirAnti-viralsDebiopharmNovartisPharmaceuticalResearch

7885 to 7909 of 8753 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top